Halozyme Therapeutics, Inc. (HALO)

Halozyme Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Revenue	481	376.71	451.77	354.26	325.72	264.86	298.01	290.08	231.35	195.88	230.04	216.03	221.04	162.14	181.5	208.98	152.37	117.28	102	115.83
Revenue Growth (YoY)	47.67%	42.23%	51.60%	22.13%	40.79%	35.22%	29.55%	34.28%	4.67%	20.81%	26.75%	3.38%	45.07%	38.25%	77.93%	80.42%	11.66%	31.74%	-16.19%	77.34%
Cost of Revenue	106.84	104.8	110.67	72.49	63.9	63.2	62.5	67.88	60.65	47.44	73.63	72.14	69.8	53.15	64.69	64.02	49.43	27.78	31.7	27.08
Gross Profit	374.16	271.91	341.1	281.77	261.82	201.66	235.51	222.2	170.71	148.44	156.41	143.89	151.24	108.99	116.81	144.95	102.94	89.5	70.31	88.76
Selling, General & Admin	57	57.88	63.33	46.09	41.61	42.36	42.25	41.24	35.71	35.13	37.61	35.27	38.95	37.36	15.85	34.47	57.48	13.83	13.77	13.17
Amortization of Goodwill & Intangibles	29.51	29.51	23.38	17.76	17.76	17.76	17.76	17.76	17.76	17.76	17.76	17.84	17.84	17.84	4.55	27.19	11.4	-	-	-
Operating Expenses	86.51	87.39	86.7	63.85	59.38	60.12	60.01	59	53.47	52.9	55.37	53.11	56.78	55.19	20.4	61.66	68.88	13.83	13.77	13.17
Operating Income	287.65	184.52	254.4	217.92	202.44	141.54	175.5	163.2	117.24	95.54	101.04	90.78	94.46	53.8	96.41	83.29	34.06	75.67	56.53	75.59
Interest Expense	-5.59	-5.51	-4.91	-4.3	-4.39	-4.53	-4.54	-4.52	-4.52	-4.51	-5.22	-4.51	-4.49	-4.54	-5.32	-7.51	-3.1	-1.76	-3.24	-1.75
Interest & Investment Income	2.84	1.29	2.09	5.33	6.89	5.11	4.86	6.47	-	2.62	2.87	4.79	3.19	2.06	-	0.64	-	1.04	-	0.27
Other Non Operating Income (Expenses)	-	-	-	-	-	-	-	-	5.03	-	-	-	-	-	-	-	-	-	-	-
EBT Excluding Unusual Items	284.9	180.3	251.58	218.96	204.94	142.12	175.82	165.15	117.74	93.66	98.69	91.06	93.16	51.32	91.09	76.42	30.96	74.95	53.29	74.11
Merger & Restructuring Charges	-	-	-13.7	-	-	-	-	-	-	-	-	-	-	-	-21.9	-	-	-	-	-
Gain (Loss) on Sale of Investments	-	0.03	0.34	-	-	1.71	2.4	-	-	2.37	2.49	-	-	0.92	1.61	-	-0.95	-0.54	1.52	-
Asset Writedown	-	-	-48.7	-	-	-	-	-	-	-	-	-2.5	-	-	-	-	-	-	-	-
Other Unusual Items	-	-	-5.48	-	-	-	-	-	-	-	-	13.2	-	-	-	-2.71	-	-	-	-
Pretax Income	284.9	180.33	-100.85	218.96	204.94	143.83	178.21	165.15	117.74	96.03	101.18	101.76	93.16	52.24	70.79	73.71	30.01	74.41	54.81	74.11
Income Tax Expense	54.99	30.28	40.74	43.73	39.78	25.73	41.2	28.14	24.5	19.21	15.79	19.92	18.4	12.62	13.09	12.07	7.33	14.3	-11.96	-142.48
Net Income	229.91	150.05	-141.59	175.23	165.16	118.1	137.01	137.01	93.25	76.82	85.39	81.84	74.75	39.62	57.7	61.63	22.69	60.11	66.77	216.59
Net Income to Common	229.91	150.05	-141.59	175.23	165.16	118.1	137.01	137.01	93.25	76.82	85.39	81.84	74.75	39.62	57.7	61.63	22.69	60.11	66.77	216.59
Net Income Growth (YoY)	39.21%	27.06%	-	27.89%	77.13%	53.72%	60.46%	67.42%	24.74%	93.92%	47.98%	32.78%	229.53%	-34.09%	-13.58%	-71.54%	-75.20%	115.48%	-8.74%	498.19%
Shares Outstanding (Basic)	117	118	118	117	121	123	126	127	127	127	129	132	132	135	135	137	138	138	140	142
Shares Outstanding (Diluted)	121	123	118	122	124	127	129	130	129	129	131	134	134	138	139	139	142	141	144	147
Shares Change (YoY)	-2.37%	-2.98%	-8.77%	-6.00%	-3.92%	-1.74%	-1.57%	-2.94%	-3.24%	-6.54%	-5.46%	-3.81%	-6.10%	-2.39%	-3.92%	-4.98%	-3.66%	-4.89%	-0.60%	3.24%
EPS (Basic)	1.96	1.27	-1.20	1.49	1.36	0.96	1.08	1.08	0.73	0.61	0.66	0.62	0.57	0.29	0.43	0.45	0.16	0.44	0.48	1.53
EPS (Diluted)	1.90	1.22	-1.20	1.43	1.33	0.93	1.06	1.05	0.72	0.60	0.65	0.61	0.56	0.29	0.42	0.44	0.16	0.43	0.45	1.48
EPS Growth (YoY)	42.86%	31.18%	-	36.19%	84.72%	55.00%	62.30%	72.13%	28.57%	106.90%	54.64%	38.64%	250.00%	-32.56%	-6.93%	-70.27%	-74.19%	126.32%	-9.31%	492.00%

Additional Metrics

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Free Cash Flow	236.72	176.34	217.6	175.57	98.15	153.27	175.42	113.86	53.21	125.88	99.76	129.47	68.47	75.59	80.11	68.63	39.26	47.31	82.36	121.24
Free Cash Flow Per Share	1.95	1.44	1.85	1.44	0.79	1.21	1.36	0.88	0.41	0.98	0.76	0.97	0.51	0.55	0.58	0.49	0.28	0.34	0.57	0.83
Gross Margin	77.79%	72.18%	75.50%	79.54%	80.38%	76.14%	79.03%	76.60%	73.79%	75.78%	67.99%	66.61%	68.42%	67.22%	64.36%	69.36%	67.56%	76.32%	68.93%	76.63%
Operating Margin	59.80%	48.98%	56.31%	61.51%	62.15%	53.44%	58.89%	56.26%	50.67%	48.78%	43.92%	42.02%	42.73%	33.18%	53.12%	39.86%	22.35%	64.52%	55.42%	65.26%
Profit Margin	47.80%	39.83%	-31.34%	49.46%	50.71%	44.59%	45.98%	47.23%	40.30%	39.22%	37.12%	37.88%	33.82%	24.43%	31.79%	29.49%	14.89%	51.25%	65.46%	186.99%
Free Cash Flow Margin	49.21%	46.81%	48.17%	49.56%	30.13%	57.87%	58.86%	39.25%	23.00%	64.27%	43.37%	59.93%	30.97%	46.62%	44.14%	32.84%	25.77%	40.34%	80.74%	104.67%
EBITDA	319.12	215.65	279.08	236.84	221.44	160.48	194.52	182.16	136.07	114.35	120.43	109.96	113.69	72.86	102.22	111.8	46.01	76.05	56.91	75.94
EBITDA Margin	66.34%	57.25%	61.77%	66.85%	67.99%	60.59%	65.27%	62.80%	58.81%	58.38%	52.35%	50.90%	51.43%	44.94%	56.32%	53.50%	30.20%	64.84%	55.79%	65.56%
D&A For EBITDA	31.47	31.13	24.68	18.92	19	18.95	19.02	18.96	18.83	18.81	19.39	19.18	19.23	19.06	5.81	28.5	11.95	0.38	0.37	0.35
EBIT	287.65	184.52	254.4	217.92	202.44	141.54	175.5	163.2	117.24	95.54	101.04	90.78	94.46	53.8	96.41	83.29	34.06	75.67	56.53	75.59
EBIT Margin	59.80%	48.98%	56.31%	61.51%	62.15%	53.44%	58.89%	56.26%	50.67%	48.78%	43.92%	42.02%	42.73%	33.18%	53.12%	39.86%	22.35%	64.52%	55.42%	65.26%
Effective Tax Rate	19.30%	16.79%	-	19.97%	19.41%	17.89%	23.12%	17.04%	20.81%	20.00%	15.60%	19.58%	19.75%	24.16%	18.49%	16.38%	24.41%	19.22%	-	-
Revenue as Reported	481	376.71	451.77	354.26	325.72	264.86	298.01	290.08	231.35	195.88	230.04	216.03	221.04	162.14	181.5	208.98	152.37	117.28	102	115.83

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 6, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 29, 2026

Data Sources Report a data error